Takeda Pharmaceutical Shares Outstanding 2007-2020 | TAK

Takeda Pharmaceutical shares outstanding history from 2007 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Takeda Pharmaceutical shares outstanding for the quarter ending December 31, 2020 were 3.151B, a 1.15% increase year-over-year.
  • Takeda Pharmaceutical 2020 shares outstanding were 3.132B, a 61.98% increase from 2019.
  • Takeda Pharmaceutical 2019 shares outstanding were 1.934B, a 22.9% increase from 2018.
  • Takeda Pharmaceutical 2018 shares outstanding were 1.573B, a 0.1% increase from 2017.
Takeda Pharmaceutical Annual Shares Outstanding
(Millions of Shares)
2020 3,132
2019 1,934
2018 1,573
2017 1,572
2016 1,576
2015 1,573
2014 1,581
2013 1,579
2012 1,579
2011 1,579
2010 1,579
2009 1,617
2008 1,697
2007 1,740
2006 1,772
Takeda Pharmaceutical Quarterly Shares Outstanding
(Millions of Shares)
2020-12-31 3,151
2020-09-30 3,146
2020-06-30 3,118
2020-03-31 3,132
2019-12-31 3,115
2019-09-30 3,124
2019-06-30 3,111
2018-12-31 1,573
2018-06-30 1,564
2017-06-30 1,560
2016-06-30 1,564
2015-06-30 1,570
2015-03-31 1,574
2014-12-31 1,578
2014-09-30 1,572
2014-06-30 1,575
2014-03-31 1,578
2013-12-31 1,581
2013-09-30 1,578
2013-06-30 1,581
2013-03-31 1,580
2012-12-31 1,579
2012-09-30 1,579
2012-06-30 1,579
2012-03-31 1,579
2011-12-31 1,578
2011-09-30 1,582
2011-03-31 1,579
2010-03-31 1,579
2009-09-30 6
2009-03-31 1,588
2008-03-31 1,940
2007-03-31 1,716
2006-03-31 1,790
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $53.899B $30.200B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.622B 43.54
Astellas Pharma (ALPMY) Japan $28.188B 17.40
Eisai (ESALY) Japan $19.828B 21.99
Catalent (CTLT) United States $18.827B 49.82
Grifols, S.A (GRFS) Spain $12.362B 14.38
Jazz Pharmaceuticals (JAZZ) Ireland $9.513B 15.89
Neurocrine Biosciences (NBIX) United States $9.130B 21.04
United Therapeutics (UTHR) United States $9.075B 17.62
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.997B 0.00
IPSEN SA ADR (IPSEY) France $7.765B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $7.022B 0.00
Evotec AG (EVTCY) Germany $6.594B 445.28
Orion OYJ (ORINY) Finland $5.789B 0.00
Ionis Pharmaceuticals (IONS) United States $5.744B 0.00
Sage Therapeutics (SAGE) United States $4.358B 0.00
Hypermarcas (HYPMY) Brazil $3.972B 15.68
Turning Point Therapeutics (TPTX) United States $3.577B 0.00
Nektar Therapeutics (NKTR) United States $3.464B 0.00
PTC Therapeutics (PTCT) United States $3.417B 0.00
ChemoCentryx (CCXI) United States $3.246B 0.00
Cronos Group (CRON) Canada $3.012B 0.00
Revolution Medicines (RVMD) United States $2.959B 0.00
Tilray (TLRY) Canada $2.954B 0.00
Relay Therapeutics (RLAY) United States $2.947B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.894B 17.92
Pacira BioSciences (PCRX) United States $2.766B 46.72
Organogenesis Holdings (ORGO) United States $2.747B 165.08
Corcept Therapeutics (CORT) United States $2.671B 26.78
Xencor (XNCR) United States $2.449B 0.00
USANA Health Sciences (USNA) United States $2.039B 16.88
BioCryst Pharmaceuticals (BCRX) United States $1.997B 0.00
FibroGen (FGEN) United States $1.833B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.766B 11.33
Ironwood Pharmaceuticals (IRWD) United States $1.708B 13.43
Heron Therapeutics (HRTX) United States $1.633B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.574B 0.00
ImmunoGen (IMGN) United States $1.502B 0.00
Endo (ENDP) Ireland $1.443B 2.18
AlloVir (ALVR) United States $1.438B 0.00
Translate Bio (TBIO) United States $1.417B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.416B 0.00
Sundial Growers (SNDL) Canada $1.406B 0.00
Aclaris Therapeutics (ACRS) United States $1.382B 0.00
Indivior (INVVY) United States $1.363B 0.00
Ocular Therapeutix (OCUL) United States $1.209B 0.00
Zogenix (ZGNX) United States $1.060B 0.00
Trillium Therapeutics (TRIL) Canada $1.028B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.022B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Radius Health (RDUS) United States $0.924B 0.00
4D Molecular Therapeutics (FDMT) $0.886B 0.00
Vectura Group (VEGPF) United Kingdom $0.864B 0.00
Ardelyx (ARDX) United States $0.858B 0.00
Bioventus (BVS) United States $0.842B 0.00
Collegium Pharmaceutical (COLL) United States $0.819B 30.62
Aerie Pharmaceuticals (AERI) United States $0.809B 0.00
Esperion Therapeutics (ESPR) United States $0.761B 0.00
Karyopharm Therapeutics (KPTI) United States $0.729B 0.00
Silence Therapeutics (SLN) United Kingdom $0.689B 0.00
Chinook Therapeutics (KDNY) United States $0.674B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.671B 0.00
Rafael Holdings (RFL) United States $0.657B 0.00
Harpoon Therapeutics (HARP) United States $0.648B 0.00
VAXART, INC (VXRT) United States $0.630B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.609B 0.00
KalVista Pharmaceuticals (KALV) United States $0.594B 0.00
Nanobiotix S.A (NBTX) France $0.570B 0.00
Siga Technologies (SIGA) United States $0.557B 9.31
Crinetics Pharmaceuticals (CRNX) United States $0.553B 0.00
Sigilon Therapeutics (SGTX) $0.537B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.517B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.504B 0.00
Flexion Therapeutics (FLXN) United States $0.470B 0.00
TherapeuticsMD (TXMD) United States $0.466B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.461B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.461B 10.83
Altimmune (ALT) United States $0.456B 0.00
Molecular Templates (MTEM) United States $0.455B 0.00
Akebia Therapeutics (AKBA) United States $0.454B 0.00
AVITA Medical (RCEL) United States $0.447B 0.00
Summit Therapeutics (SMMT) United States $0.444B 0.00
Foghorn Therapeutics (FHTX) United States $0.423B 0.00
Jounce Therapeutics (JNCE) United States $0.413B 0.00
PROFOUND MEDICL (PROF) Canada $0.409B 0.00
Nature's Sunshine Products (NATR) United States $0.400B 19.08
DURECT (DRRX) United States $0.389B 0.00
MEI Pharma (MEIP) United States $0.380B 0.00
Acutus Medical (AFIB) United States $0.362B 0.00
Innate Pharma SA (IPHYF) France $0.352B 0.00
Redhill Biopharma (RDHL) Israel $0.329B 0.00
Oncternal Therapeutics (ONCT) United States $0.320B 0.00
Clever Leaves Holdings (CLVR) United States $0.276B 0.00
VYNE Therapeutics (VYNE) United States $0.274B 0.00
Infinity Pharmaceuticals (INFI) United States $0.264B 0.00
Alpine Immune Sciences (ALPN) United States $0.263B 0.00
Taiwan Liposome (TLC) Taiwan $0.252B 0.00
Inotiv (NOTV) United States $0.250B 0.00
CASI Pharmaceuticals (CASI) United States $0.250B 0.00
KemPharm (KMPH) United States $0.244B 0.00
Xeris Pharmaceuticals (XERS) United States $0.234B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.231B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.215B 0.00
4D Pharma (LBPS) United Kingdom $0.213B 0.00
Sierra Oncology (SRRA) Canada $0.209B 0.00
Progenity (PROG) United States $0.203B 0.00
Lannett Co Inc (LCI) United States $0.197B 6.61
Iterum Therapeutics (ITRM) Ireland $0.194B 0.00
CTI BioPharma (CTIC) United States $0.189B 0.00
IMV INC (IMV) Canada $0.187B 0.00
OptiNose (OPTN) United States $0.186B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.179B 0.00
Jaguar Animal Health (JAGX) United States $0.169B 0.00
Novan (NOVN) United States $0.167B 0.00
Heat Biologics (HTBX) United States $0.164B 0.00
Gain Therapeutics (GANX) United States $0.164B 0.00
Adherex Technologies (FENC) United States $0.163B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.163B 0.00
SCYNEXIS (SCYX) United States $0.159B 0.00
Calithera Biosciences (CALA) United States $0.158B 0.00
Vivos Therapeutics (VVOS) $0.152B 0.00
Qilian Holding Group (QLI) China $0.149B 0.00
Champions Oncology (CSBR) United States $0.148B 0.00
Aquestive Therapeutics (AQST) United States $0.147B 0.00
Onconova Therapeutics (ONTX) United States $0.143B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.143B 0.00
Concert Pharmaceuticals (CNCE) United States $0.142B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.138B 0.00
MediWound (MDWD) Israel $0.137B 0.00
GlycoMimetics (GLYC) United States $0.135B 0.00
Nutriband (NTRB) United States $0.133B 0.00
Aziyo Biologics (AZYO) United States $0.132B 0.00
Lipocine (LPCN) United States $0.129B 0.00
Genocea Biosciences (GNCA) United States $0.118B 0.00
Natural Alternatives (NAII) United States $0.116B 31.38
La Jolla Pharmaceutical (LJPC) United States $0.112B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.109B 0.00
Minerva Neurosciences (NERV) United States $0.109B 42.33
Otonomy (OTIC) United States $0.107B 0.00
PolarityTE (PTE) United States $0.106B 0.00
Savara (SVRA) United States $0.095B 0.00
Regulus Therapeutics (RGLS) United States $0.094B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.090B 0.00
ElectroCore (ECOR) United States $0.087B 0.00
Recro Pharma (REPH) United States $0.086B 0.00
Assertio Holdings (ASRT) United States $0.084B 0.00
ProPhase Labs (PRPH) United States $0.081B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.077B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.075B 0.00
Baudax Bio (BXRX) United States $0.075B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.071B 0.00
Sigyn Therapeutics (SIGY) United States $0.068B 0.00
Addex Therapeutics (ADXN) Switzerland $0.068B 0.00
RENEURON GP (RNUGF) United Kingdom $0.062B 0.00
Biomerica (BMRA) United States $0.058B 0.00
Brickell Biotech (BBI) United States $0.057B 0.00
IntelGenx Technologies (IGXT) Canada $0.054B 0.00
Inhibikase Therapeutics (IKT) United States $0.053B 0.00
HANCOCK JAFFE (HJLI) United States $0.052B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.051B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.047B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.045B 59.80
Viracta Therapeutics (VIRX) United States $0.041B 0.00
Mannatech (MTEX) United States $0.040B 7.03
RXi Pharmaceuticals (PHIO) United States $0.031B 0.00
Petros Pharmaceuticals (PTPI) United States $0.031B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.031B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.027B 0.00
Midatech Pharma (MTP) United Kingdom $0.024B 0.00
JanOne (JAN) United States $0.021B 0.00
China SXT Pharmaceuticals (SXTC) China $0.020B 0.00
Plus Therapeutics (PSTV) United States $0.019B 0.00
Cyanotech (CYAN) United States $0.019B 15.70
Sonoma Pharmaceuticals (SNOA) United States $0.018B 0.00
SHINECO INC (TYHT) China $0.018B 0.00
Xenetic Biosciences (XBIO) United States $0.017B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00